Cefoxitin And Dextrose Injection, Solution
Product Images NDC 0264-3125

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cefoxitin And Dextrose (NDC 0264-3125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefoxitin Sodium (Cefoxitin For Injection And Dextrose Injection In 1)

An instructional diagram labeled 'Diagram 1' showing the packaging of an injection vial with a highlighted 'Side Tab' meant to be pulled to open or access the vial within the packaging.*

FDA Label Image

3125-11 50ml 2g Container Label (Cefoxitin For Injection And Dextrose Injection In 10)

Cefoxitin for Injection and Dextrose Injection 2 g in 50 mL duplex container by B. Braun Medical Inc. The label provides mixing instructions, reconstitution guidelines for intravenous use, storage conditions, and safety advice. It includes NDC numbers, a barcode, and lot and expiration placeholders.*

FDA Label Image

Drug Chamber Label (Cefoxitin For Injection And Dextrose Injection In 11)

A drug chamber instruction panel for Cefoxitin and Dextrose injection solution. It advises discarding the unit if the foil strip is damaged, peeling the foil strip only when ready for use, and visually inspecting the drug before reconstitution. It references the package insert for full reconstitution and administration directions.*

FDA Label Image

Dextrous Hydrous (Cefoxitin For Injection And Dextrose Injection In 2)

An instructional diagram illustrating the components of a Cefoxitin and Dextrose injection system. It labels the diluent chamber, foil strip with a peel area, drug powder chamber, and a set port with foil cover, along with a hanger tab at the top for suspension.*

FDA Label Image

Diagram 1 (Cefoxitin For Injection And Dextrose Injection In 3)

An instructional diagram labeled as Diagram 3 showing a pair of hands holding and possibly twisting or manipulating a component of the Cefoxitin and Dextrose injection solution container, likely indicating a step in preparation or assembly of the intravenous injection.*

FDA Label Image

Diagram 2 (Cefoxitin For Injection And Dextrose Injection In 4)

An instructional diagram showing hands manipulating a medical device component, likely illustrating a step in preparing a Cefoxitin and Dextrose intravenous injection solution. The image highlights a downward motion with an arrow indicating the direction of movement on the device.*

FDA Label Image

Diagram 3 (Cefoxitin For Injection And Dextrose Injection In 5)

An instructional diagram illustrating a medical pouch labeled with a set port and a foil cover, demonstrating how to remove or access the foil cover by lifting or peeling it away. The container shape suggests it is used for intravenous solution administration.*

FDA Label Image

Diagram 4 (Cefoxitin For Injection And Dextrose Injection In 6)

Chemical structure of cefoxitin sodium, depicting the molecular arrangement of atoms including sulfur, oxygen, nitrogen, and carbon components characteristic of this antibiotic.*

FDA Label Image

Diagram 5 (Cefoxitin For Injection And Dextrose Injection In 7)

Chemical structure of the active ingredient in Cefoxitin and Dextrose injection, solution. The diagram illustrates a molecular ring with multiple hydroxyl (OH) groups and additional chemical bonds characteristic of the compound.*

FDA Label Image

3123-11 50 mL 1g Container Label (Cefoxitin For Injection And Dextrose Injection In 8)

Label for Cefoxitin and Dextrose Injection, 1 g per 50 mL intravenous injection solution by B. Braun Medical Inc. The label includes usage instructions, reconstitution directions, storage conditions, and drug information emphasizing the single-dose use and the container features. The label shows product identification with REF and NDC numbers, expiration and lot number fields, and storage warnings for stability and safety.*

FDA Label Image

Drug Chamber Label (Cefoxitin For Injection And Dextrose Injection In 9)

Text panel titled 'Drug Chamber' advising to discard the unit if the foil strip is damaged and to peel the foil strip only when ready for use. It instructs to visually inspect the drug before reconstitution and refers to the package insert for complete directions on reconstitution and administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.